4Filing Date: Mar 17, 2026

Guardant Health (GH) 4: Saia John G. bought 7,792 shares of Common Stock at $N/A on… (Mar 17, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001737840-26-000006
Total Value$395.1K
Trades5
Insiders1

Transaction Details

Saia John G.
Chief Legal Officer·Direct
Exercise · Dispose
Performance-Based Restricted Stock UnitsDerivative
Shares-7.79K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateMar 15, 2026
Footnotes ▸

This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026. | Not applicable for Restricted Stock Units.

Saia John G.
Chief Legal Officer·Direct
Tax W/H · Dispose
Common Stock
Shares-4.62K
Price$85.49
Total Value$395.1K
Shares Owned After56.90K
Transaction DateMar 15, 2026
Footnotes ▸

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Saia John G.
Chief Legal Officer·Direct
Exercise · Acquire
Common Stock
Shares+7.79K
Price$0.00
Total Value$0
Shares Owned After60.51K
Transaction DateMar 15, 2026
Saia John G.
Chief Legal Officer·Direct
Exercise · Acquire
Common Stock
Shares+1.02K
Price$0.00
Total Value$0
Shares Owned After61.52K
Transaction DateMar 15, 2026
Saia John G.
Chief Legal Officer·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-1.02K
Price$0.00
Total Value$0
Shares Owned After1.02K
Transaction DateMar 15, 2026
Footnotes ▸

This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.

Post-Transaction Holdings

Saia John G. · Chief Legal Officer
SecuritySharesChange
Common Stock56.90K+4.19K (7.95%)
Performance-Based Restricted Stock Units0-7.79K (-100.00%)
Restricted Stock Units1.02K-1.02K (-49.98%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-03-15 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: Saia John G. CIK: 0001737840 Role: Officer (Chief Legal Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-03-15 | Code: M (Exercise of derivative) Shares: +7,792 | Price: $0.00 Shares Owned After: 60,506 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-03-15 | Code: M (Exercise of derivative) Shares: +1,019 | Price: $0.00 Shares Owned After: 61,525 | Ownership: D (Direct) [Transaction #3] Security: Common Stock Date: 2026-03-15 | Code: F (Payment of exercise/tax) Shares: -4,622 | Price: $85.49 Total Value: $395,134.78 Shares Owned After: 56,903 | Ownership: D (Direct) Footnotes: [F1] These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. --- Derivative Transactions --- [Transaction #1] Security: Performance-Based Restricted Stock Units Date: 2026-03-15 | Code: M (Exercise of derivative) Shares: -7,792 | Price: $0.00 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F2] This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026. [F3] Not applicable for Restricted Stock Units. [Transaction #2] Security: Restricted Stock Units Date: 2026-03-15 | Code: M (Exercise of derivative) Shares: -1,019 | Price: $0.00 Shares Owned After: 1,020 | Ownership: D (Direct) Footnotes: [F4] This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. [F3] Not applicable for Restricted Stock Units. --- Footnotes (Complete Index) --- F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. F2: This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026. F3: Not applicable for Restricted Stock Units. F4: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. --- Signature --- /s/ /s/ John G. Saia (2026-03-17)

keid analysis is for reference only and does not constitute investment advice.